Veru

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veru and other ETFs, options, and stocks.

About VERU

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines and treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. 

CEO
Mitchell Shuster Steiner
CEOMitchell Shuster Steiner
Employees
20
Employees20
Headquarters
Miami, Florida
HeadquartersMiami, Florida
Founded
1971
Founded1971
Employees
20
Employees20

VERU Key Statistics

Market cap
33.71M
Market cap33.71M
Price-Earnings ratio
-2.61
Price-Earnings ratio-2.61
Dividend yield
Dividend yield
Average volume
68.30K
Average volume68.30K
High today
$2.20
High today$2.20
Low today
$2.07
Low today$2.07
Open price
$2.13
Open price$2.13
Volume
32.11K
Volume32.11K
52 Week high
$7.40
52 Week high$7.40
52 Week low
$2.05
52 Week low$2.05

Stock Snapshot

Veru(VERU) stock is priced at $2.11, giving the company a market capitalization of 33.71M. It carries a P/E multiple of -2.61.

During the trading session on 2026-05-19, Veru(VERU) shares reached a daily high of $2.20 and a low of $2.07. At a current price of $2.11, the stock is +1.9% higher than the low and still -4.1% under the high.

Trading volume for Veru(VERU) stock has reached 32.11K, versus its average volume of 68.3K.

The stock's 52-week range extends from a low of $2.05 to a high of $7.40.

The stock's 52-week range extends from a low of $2.05 to a high of $7.40.

VERU News

TipRanks 5d
Veru price target lowered to $24 from $25 at Oppenheimer

Oppenheimer lowered the firm’s price target on Veru (VERU) to $24 from $25 to reflect the company’s Q2 results. The firm keeps an Outperform rating on the share...

TipRanks 6d
Veru Inc. Earnings Call Highlights Clinical Momentum

Veru Inc ((VERU)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and powerful i...

The Motley Fool 6d
Veru Q2 2026 Earnings Transcript

Image source: The Motley Fool. Wednesday, May 13, 2026 at 8 a.m. ET CALL PARTICIPANTS Chairman, President, and Chief Executive Officer — Mitchell Steiner Chief...

Veru Q2 2026 Earnings Transcript

More VERU News

TipRanks 7d
Veru reports Q2 EPS (37c) vs. ($1.15) last year

Cash, cash equivalents and restricted cash were $27.6M as of March 31 versus $15.8M as of September 30, 2025. “We are extremely pleased with the progress of the...

People also own

Based on the portfolios of people who own VERU. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.